Dr. Ingmar Gorman is a co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike. Dr. Gorman received his clinical training in New York City at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University. He simultaneously served as site co-principal investigator on an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and is currently a study therapist on the same study, as well as another FDA approved clinical trial of psilocybin for treatment resistant depression. Dr. Gorman has published on the topics of classic psychedelics, ketamine, MDMA, and Psychedelic Harm Reduction and Integration.
Psychedelic-Assisted Psychotherapy is a technique that involves the use of drugs that produce a psychedelic effect in order to assist in the psychotherapy process. The U.S. Food and Drug Administration (FDA) named psilocybin-assisted therapy as a “breakthrough therapy.” Over the last two decades, researchers have received approval from governmental authorities to conduct trials on the use of the psychedelic substances to treat various conditions. What researchers have found is that psychedelic substances can have beneficial therapeutic effects. According to the research, there are a number of potential applications for psychedelic therapy such as anxiety, depression, substance use, alcohol use, and PTSD. At present, there are multiple clinical trials on psychedelic assisted therapy, some in phase II and III.
TherapyShow.com/Psychedelic-Assisted-Psychotherapy
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Twitter @Fluencetraining
Disclaimer: The information shared in this podcast is not a substitute for getting help from a mental health professional.
#63 Dr. Deborah Korn on EMDR: A Proven Treatment for PTSD and Complex PTSD
#62 Dr. Nicole Stadnick, Autism Expert, on Why an Integrated Approach to Treatment is Critical
#61 Dr. Elizabeth Nielson on Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder: Possible Anti-Addictive Properties
#60 Dr. William Miller on Motivational Interviewing: A Powerful Therapy for Mental Health and Physical Health
#59 Dr. Stefan Hofmann on Simple CBT and Mindfulness Strategies to Overcome Anxiety, Fear, and Worry
#57 Dr. Steven Hayes Developed ACT to Help Individuals Balance Acceptance and Change Leading to Emotional Flexibility
#56 Dr. Elaine Walker, Renowned Schizophrenia Expert, on Why Early Intervention is Critical to Effective Treatment
#55 Dr. Frederic Reamer on Boundary Issues and Dual Relationships in Social Work Practice
#54 DBT in Schools: Teach Kids Social Emotional Skills BEFORE They Develop a Mental Disorder
#53 Dr. Patricia Resick on Cognitive Processing Therapy: A Gold Standard Treatment for PTSD
#52 Dr. Molyn Leszcz, President of APGA, on the Effectiveness of Evidence-Based Group Psychotherapy to Heal Mental Illness
#51 Dr. John Norcross Explains Individual Psychotherapy and Why it Works
#50 Dr. Judith Beck Explains How Everyone Could Benefit From Learning CBT
#49 Dr. Patrick Corrigan on Why Understanding Stigma is Key to Mental Health
#48 Dr. Lawrence Shulman on Parallel Process in Social Work Supervision
#47 Dialectical Behavior Therapy: Why We Can All Use More Skills. Dr. Vibh Forsythe Cox Interview
#46 Bipolar Disorder: A "Patient Centric" Approach to Treatment. Dr. Gary Sachs Interview
#45 Dr. Myrna Weissman on Interpersonal Psychotherapy: a Time Sensitive Evidence-Based Therapy
#44 A look into Mobile Crisis in New Jersey with Sean Cullen, LPC
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Your Sleep Guru Podcast
Anxiety Slayer™ with Shann and Ananga
Men Do Talk Podcast
The Dr. John Delony Show
On Purpose with Jay Shetty